TAp63: A Novel Drug Target Candidate for Rheumatoid Arthritis Treatment
Upon understanding the mechanism behind the current MTX treatment commonly used to treat Rheumatoid Arthritis, researchers discovered another potential treatment option using TAp63 protein as a drug...